Atlas

Form 483

Medical Products Laboratories, Inc. Form 483, 2023-07-13

FDA issued a Form 483 to Medical Products Laboratories, Inc. on 2023-07-13 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Medical Products Laboratories, Inc. · Philadelphia, United States · Issued July 13, 2023

Overview

  • 2 public-safe observations are available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

13 Jul 2023
21 CFR 211.63

Equipment Design, Size and Location

Cited by Daniel J Min

13 Jul 2023
21 CFR 211.63

Equipment Design, Size and Location

Cited by Daniel J Min

Inspected site

MPMedical Products Laboratories, Inc.Philadelphia, United States

Inspection team

DJDaniel J Min

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.63Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Book a demoStart a free trial

Full 483 report

Get the verbatim text of all 2 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere